Bayer to stop sales of birth control device tied to injuries
WASHINGTON (AP) - The maker of a permanent contraceptive implant subject to thousands of injury reports from women and repeated safety restrictions by regulators, says it will stop selling the device in the U.S.
Bayer said Friday the safety of its Essure implant has not changed and it will stop selling the device at the end of the year due to weak sales. Last year, Bayer stopped selling the device in Europe.
The Food and Drug Administration has placed multiple restrictions on the device following patient reports of pain, bleeding, allergic reactions and cases where the implant punctured the uterus or shifted out of place. In May, the FDA said doctors must show women a checklist of the device's risks before implanting it.
More than 16,000 U.S. women are suing Bayer over Essure.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Teen who tried to break up fight dies in hospital; 2 facing...
Children found parents dead at Maringouin home after possible murder-suicide
CATS to start process of deciding interim CEO's new salary; still paying...
World's first fully-automated, smallest and fastest drive-thru kitchen produced in Baton Rouge
See BREC's plans for fairgrounds that prompted State Fair move
VIDEO: Devery Henderson Talk about Bluegrass Miracle and the Saints "Rebirth game"
VIDEO: Former Tigers and Saints receiver Devery Henderson talks with Corey Rholdon...
Saints release 2022 schedule, will open season on the road at Atlanta
St. Amant baseball heading to first state semifinals since 2014
Southern slugs out sweep against UAPB